Literature DB >> 9400764

Vitreous surgery for chronic macular holes.

D B Roth1, W E Smiddy, W Feuer.   

Abstract

OBJECTIVE: The purpose of the study is to compare the results of vitreous surgery for a group of patients with chronic macular holes with a group of patients with acute-onset macular holes undergoing identical surgery.
DESIGN: A case-control study design was used. PARTICIPANTS: The duration of symptoms of visual loss due to macular holes was greater than 1 year's duration in 11 eyes in each group consecutively operated on within a few days. INTERVENTION: All patients underwent macular hole surgery. MAIN OUTCOME MEASURES: Ophthalmoscopic resolution of the macular hole, improvement of 2 lines of visual acuity or greater, improvement in mean and median visual acuity, and rate of 20/40 or greater final visual acuity.
RESULTS: The hole resolved in 9 of 11 eyes in the chronic group and 10 of 11 eyes in the acute group. The mean (median) preoperative visual acuity was 20/151 (20/200) in the chronic group and 20/139 (20/200) in the acute group. The 3-month mean (median) postoperative visual acuity was 20/85 (20/80) in the chronic group and 20/62 (20/63) in the acute group. The final mean (median) postoperative visual acuity was 20/96 (20/ 100) in the chronic group and 20/48 (20/50) in the acute group (P = 0.022). The mean interval to final follow-up examination was 70 weeks for the chronic group and 44 weeks for the acute group. Five (45%) of 11 eyes with chronic holes and 8 (73%) of 11 eyes in the acute group had a final visual acuity of 2 lines or better than the preoperative visual acuity. Cataract extraction had been performed by the final follow-up examination in 7 chronic eyes (64%) and 2 acute eyes (18%).
CONCLUSIONS: Chronic macular holes have a similar anatomic success rate, but a poorer visual prognosis than acute holes after macular hole surgery. Vitreous surgery benefits some patients with idiopathic macular holes of greater than 1 year's duration.

Entities:  

Mesh:

Year:  1997        PMID: 9400764     DOI: 10.1016/s0161-6420(97)30060-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

1.  Glial proliferation after vitrectomy for a macular hole: a spectral domain optical coherence tomography study.

Authors:  Jaeryung Oh; Sun Mo Yang; Yong Min Choi; Seong-Woo Kim; Kuhl Huh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-24       Impact factor: 3.117

2.  Correlation between central retinal thickness after successful macular hole surgery and visual outcome.

Authors:  Yoshihiro Takamura; Takeshi Tomomatsu; Takehiro Matsumura; Shogo Arimura; Makoto Gozawa; Yuji Takihara; Masaru Inatani
Journal:  Jpn J Ophthalmol       Date:  2015-08-29       Impact factor: 2.447

3.  Indocyanine green assisted retinal internal limiting membrane removal in stage 3 or 4 macular hole surgery.

Authors:  A K H Kwok; T Y Y Lai; W Man-Chan; D C F Woo
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

4.  Effect of preoperative retinal sensitivity and fixation on long-term prognosis for idiopathic macular holes.

Authors:  Zhongcui Sun; Dekang Gan; Chunhui Jiang; Min Wang; Alicia Sprecher; Alice C Jiang; Gezhi Xu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-03-24       Impact factor: 3.117

5.  [Vitreoretinal secondary procedures following elective macular surgery].

Authors:  A Hager; S Ehrich; W Wiegand
Journal:  Ophthalmologe       Date:  2004-01       Impact factor: 1.059

6.  Outcomes of chronic macular hole surgical repair.

Authors:  Shripaad Y Shukla; Armin R Afshar; Daniel F Kiernan; Seenu M Hariprasad
Journal:  Indian J Ophthalmol       Date:  2014-07       Impact factor: 1.848

7.  Management of Stage IV Macular Holes: When Standard Surgery Fails.

Authors:  R Reis; N Ferreira; A Meireles
Journal:  Case Rep Ophthalmol       Date:  2012-08-08

Review 8.  Optimal management of idiopathic macular holes.

Authors:  Haifa A Madi; Ibrahim Masri; David H Steel
Journal:  Clin Ophthalmol       Date:  2016-01-13

9.  Autologous neurosensory retinal flap for closure of refractory macular hole in a patient with macular telangiectasia.

Authors:  Andrew Hewson; Andrew McAllister; Ian Reddie
Journal:  Am J Ophthalmol Case Rep       Date:  2020-03-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.